![](/img/cover-not-exists.png)
A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer
Santoro, A., Comandone, A., Rimassa, L., Granetti, C., Lorusso, V., Oliva, C., Ronzoni, M., Siena, S., Zuradelli, M., Mari, E., Pressiani, T., Carnaghi, C.Volume:
19
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdn401
Date:
June, 2008
File:
PDF, 141 KB
english, 2008